Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
    • Sjögren’s Disease
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Updates on ACR Gout Guideline, FDA’s Febuxostat Warning & Pegloticase Therapy

Jason Liebowitz, MD, FACR  |  November 19, 2021

A presentation at ACR Convergence 2021 discussed the 2020 ACR Guideline for the Management of Gout, the latest information on the risk of cardiovascular death associated with febuxostat and the use of pegloticase for patients with gout.

Filed under:ACR ConvergenceClinical Criteria/GuidelinesConditionsGout and Crystalline ArthritisMeeting Reports Tagged with:ACR Convergence – GoutACR Convergence 2021ACR Convergence 2021 – GoutFebuxostatGoutpegloticase

Lupus often presents with a butterfly rash.

Top 12: Research in Systemic Lupus Erythematosus at a Glance

David S. Pisetsky, MD, PhD  |  November 18, 2021

Dr. Pisetsky’s picks for the top research in lupus presented at ACR Convergence 2021.

Filed under:ACR ConvergenceConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2021ACR Convergence 2021 – SLE

Policy Change Made Reality in 2021

Thomas R. Collins  |  November 18, 2021

After a year marked with rheumatology gains in evaluation and management valuation, as well as quality reporting, ongoing ACR efforts target impending Medicare reimbursement cuts and other practice challenges.

Filed under:ACR ConvergenceLegislation & AdvocacyMeeting Reports Tagged with:ACR advocacyACR Convergence 2021

Howard Blumstein, MD, Assumes RheumPAC Chair

Renée Bacher  |  November 18, 2021

“Advocacy is not about bribery. There’s nothing dirty about advocating for your patients and the future of your profession in terms of workforce, therapeutic advances and the financial viability of our practices. It’s our duty to do this,” he says. In his new role as the RheumPAC chair, he wants to help ACR/ARP members “see how vital these activities are to the success of our profession.”

Filed under:Legislation & AdvocacyProfiles Tagged with:AdvocacyHoward BlumsteinRheumPACVolunteering

The 2021 ACR Masters

Patrice Fusillo  |  November 14, 2021

Recognition as an ACR Master is one of the highest honors the College bestows. The designation of Master is conferred on ACR members, age 65 or older by Oct. 1 of the year in which they are nominated, who have made outstanding contributions to the ACR and the field of rheumatology through scholarly achievement and/or…

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2021Dr. Alan N. BaerDr. Alex LimanniDr. Daniel F. BattafaranoDr. David A. McLainDr. Gary S. FiresteinDr. Joanne M. JordanDr. Joel A. BlockDr. John G. HanlyDr. John J. CushDr. Maarten BoersDr. Oliver FitzGeraldDr. Paula MarchettaDr. Robert A. ColbertDr. W. Winn ChathamDr. Yukiko Kimura

The 2021 ARP President’s Awards & Merit Awards

Patrice Fusillo  |  November 14, 2021

During ACR Convergence 2021 in early November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the winners of the ARP President’s and Merit Awards. ARP PRESIDENT’S AWARDS The ARP president can choose to honor ACR/ARP…

Filed under:ACR ConvergenceAwardsMeeting Reports Tagged with:ACR Convergence 2021Association of Rheumatology Professionals (ARP)Daniel SchafferDr. Becki ClevelandDr. Catherine BackmanDr. Debbie Ehrmann-FeldmanDr. Emily C. SomersDr. Jill BlitzDr. Kamala NolaDr. Marian T. HannanDr. Monique GignacDr. Susan MurphyLinda RodamakerNorma Liburd

New Video Shows How to Perform a Lip Biopsy to Diagnose Sjögren’s Syndrome

Susan Bernstein  |  November 14, 2021

Labial salivary gland biopsy (i.e., lip biopsy) is a useful tool to help diagnose Sjögren’s syndrome in suspected patients, but most rheumatologists are not trained to perform the minimally invasive procedure. A new, 40-minute training video and slide presentation with step-by-step instructions may help them fill that critical skill gap. Two rheumatologists collaborated to create…

Filed under:ConditionsOther Rheumatic ConditionsSjögren’s Disease Tagged with:biopsySjogren's

2 ARP Volunteers Share Their Enriching Experiences

Elizabeth Hofheinz, MPH, MEd  |  November 14, 2021

It may not take a village, but when it comes to providing stellar care to rheumatology and musculoskeletal patients, it definitely takes a team. To ensure all rheumatology professionals are thoroughly prepared to serve their patients’ needs in a personalized manner, there is the ARP—the Association of Rheumatology Professionals. The ARP, the interprofessional division of…

Filed under:Interprofessional Perspective Tagged with:interdisciplinaryVolunteerism

Case Report: Rheumatoid Arthritis Complicated by Large Granular Lymphocytic Leukemia

Nam D. Nguyen, DO (Maj., USAF, MC), Erica Hill, DO (Lt. Col., USAF, MC), & Jay Higgs, MD (Col. [ret], USAF, MC)  |  November 14, 2021

Large granular lymphocytic (LGL) leukemia is a rare, chronic, lymphoproliferative disorder of cytotoxic T cell or natural killer cell lineage with an annual incidence of 0.72 cases per 1 million people in the U.S.1 The most common sub­type of LGL leukemia, T-LGL leukemia, follows an indolent disease course and accounts for approximately 85% of cases….

Filed under:ConditionsRheumatoid Arthritis Tagged with:large granular lymphocyte leukemiavertebral fracture

Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

Ashraf Raslan, MD, Dorian Infantino, MD, Roman Zuckerman, DO, & Daniel Berlin, MD  |  November 14, 2021

Giant cell arteritis (GCA) is a granulomatous vasculitis of large- and medium-sized arteries, usually affecting the cranial branches of the aortic arch. It is the most common vasculitis, with the highest risk factor being age. Accurate diagnosis and prompt initiation of therapy are of great importance to prevent serious complications, with the most feared being…

Filed under:ConditionsVasculitis Tagged with:case reportGiant Cell Arteritistocilizumab

  • « Previous Page
  • 1
  • …
  • 92
  • 93
  • 94
  • 95
  • 96
  • …
  • 331
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences